4029tv18h
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
CARRY RISK. WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED SEMAGLUTIDE AS PART OF ITS HOLISTIC ...
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
WeightWatchers' CEO embraced Ozempic. Now she's out of the company.
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
WeightWatchers: As Australian members mourn meetings, could off-brand Ozempic be program’s saviour?
Will the brand really follow through on their cancellations? And could compounded semaglutide be the once-housewife-favourite ...
Opinion
Like James Corden, I also had to give up taking Ozempic – here’s why
As a binge eater, Charlotte Cripps thought the slimming wonder drug would offer a miracle cure for her cravings. She found out the hard way that wasn’t to ...
CNN14d
Sima Sistani, who embraced Ozempic, is out as CEO of WeightWatchers
Under Sistani, the 61-year-old company bought a telehealth platform that connected patients with doctors who can prescribe weight-loss and diabetes drugs, including Ozempic and Wegovy ...
WeightWatchers CEO who oversaw diet company’s move into weight loss drugs abruptly leaves role
she led the company’s recent moves into the prescription drug weight loss business — particularly with the $106 million ...